Reduction in the COVID-19 pneumonia case fatality rate by silver nanoparticles: A randomized case study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has devastated mankind. To date, no approved treatment is available to completely combat this disease. Although many studies reported the potential of silver nanoparticles’ (AgNPs) action...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Laura Wieler, Oana Vittos, Nirmalya Mukherjee, Subhasish Sarkar
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Subjects:	COVID-19 Silver nanoparticles AgNPs Severe pneumonia Mortality Supplemental oxygenation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023016262